Standard curve
Example of Rat IL-17A standard curve in Assay Diluent .
Product Details
Product Details
Product Specification
| Antigen | IL-17A |
| Application | FCM |
| Reactivity | Rat |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8°C as supplied. |
Kit
| Precision | Intra-assay: 4.80% Inter-assay: |
| Sample type | Serum; Plasma-EDTA; Plasma-Heparin; Plasma-Citrate; Cell Culture Supernatant |
| Assay type | Sandwich (quantitative) |
| Sensitivity | 22.77 pg/mL |
| Range | 78.59 pg/mL-50000 pg/mL |
| Assay time | 70 minutes |
| Species reactivity | Rat |
Background
Interleukin-17A (IL-17A, also known as CTLA-8) is the signature pro-inflammatory cytokine of the IL-17 family, playing a pivotal role in mucosal host defense and chronic tissue inflammation. Biologically active rat IL-17A predominantly exists as a disulfide-linked homodimer composed of two 133-amino-acid mature monomers (~15 kDa unglycosylated per monomer) featuring a cysteine-knot fold and N-linked glycosylation, and can also form IL-17A/F heterodimers. Signaling through the heteromeric IL-17RA/IL-17RC receptor complex via the adaptor protein Act1, it activates NF-κB, MAPK, and C/EBP pathways. Produced mainly by Th17 cells, γδ T cells, and group 3 innate lymphoid cells (ILC3s), IL-17A stimulates epithelial and stromal cells to secrete pro-inflammatory cytokines (e.g., IL-6, G-CSF), chemokines, and antimicrobial peptides, driving neutrophil recruitment against extracellular bacteria and fungi. Mature rat IL-17A shares ~88% amino acid sequence identity with mouse IL-17A and ~63% with human IL-17A, requiring species-specific assays for reliable quantification. In basic and preclinical research, measuring rat IL-17A in serum, plasma, or cell culture supernatants is widely used in autoimmune and inflammatory disease models (such as arthritis, psoriasis, EAE, and colitis), mucosal immunity studies, and therapeutic efficacy evaluation.
Picture
Picture
CBA
Dilution Linearity
Spiked serum and plasma (EDTA, Heparin, Citrate) samples from SD, SHR, and Lewis rats, along with spiked cell culture supernatant, were pre-diluted 1:1 (v/v) with sample diluent (labeled as "Undiluted") and then serially diluted 2X, 4X, and 8X with sample diluent prior to assaying for Rat IL-17A. Data shown on the y-axis represent the measured Rat IL-17A concentrations multiplied by their respective serial dilution factors (pg/mL).
Accuracy and Spike Recovery
Serum and plasma (EDTA, Heparin, Citrate) matrices from SD, SHR, and Lewis rats—pre-diluted 1:1 (v/v) in sample diluent—along with cell culture supernatant, were spiked with high, medium, and low levels of Rat IL-17A. The y-axis displays the calculated spike recovery percentages (Spike Recovery%) across each tested matrix, demonstrating consistent recovery performance across different rat strains and biological matrices.
Sample Reactivity
Cell culture supernatants from rat splenocytes left untreated or stimulated with 5 ng/ml+0.5 μg/ml PMA/Ionomycin for 24 h (n = 3) were assayed for Rat IL-17A (pg/mL). Mean Rat IL-17A concentrations increased from 16.8 pg/mL in untreated controls to 2441.7 pg/mL in PMA/Ionomycin -treated cells. Data are presented as mean ± SD.
Protocol Diagram
